news
The Hatchet – SMHS fourth-year addresses disparities in cancer treatment for HIV patients in new initiative
/the-hatchet-smhs-fourth-year-addresses-disparities-in-cancer-treatment-for-hiv-patients-in-new-initiative
publication
Beyond Breakthrough: Optimizing the Breakthrough Therapy Designation
/beyond-breakthrough-optimizing-the-breakthrough-therapy-designation
news
Cancer Therapy Advisor – RACE Act Increases Required Pediatric Studies for Cancer Drugs
/cancer-therapy-advisor-race-act-increases-required-pediatric-studies-for-cancer-drugs
news
SelectScience – RACE act increased the number of cancer drugs with required studies for use in pediatric patients
/selectscience-race-act-increased-the-number-of-cancer-drugs-with-required-studies-for-use-in-pediatric-patients
news
Medscape – More Drugs Tested in Pediatric Cancer: RACE for Children Act
/medscape-more-drugs-tested-in-pediatric-cancer-race-for-children-act
news
Healio – RACE Act led to more required pediatric studies of cancer drugs
/healio-race-act-led-to-more-required-pediatric-studies-of-cancer-drugs
news
AACR – RACE Act Increased the Number of Cancer Drugs with Required Studies for Use in Pediatric Patients
/aacr-race-act-increased-the-number-of-cancer-drugs-with-required-studies-for-use-in-pediatric-patients
news
GlobeNewswire – Bionano Genomics Announces Release of Version 6.2 of its NxClinical Software with Significant New Capabilities for Cancer Research Applications Including HRD Analysis
/globenewswire-bionano-genomics-announces-release-of-version-6-2-of-its-nxclinical-software-with-significant-new-capabilities-for-cancer-research-applications-including-hrd-analysis
post
Optimizing Dosing in Oncology Drug Development Q & A
/optimizing-dosing-in-oncology-drug-development
news
Oncology Times – Biomarker-Driven Development of Diagnostics for Rare Diseases
/oncology-times-biomarker-driven-development-of-diagnostics-for-rare-diseases
